HomeXBRANE • STO
add
Xbrane Biopharma AB
Previous close
kr 0.16
Day range
kr 0.15 - kr 0.16
Year range
kr 0.13 - kr 8.49
Market cap
229.33M SEK
Avg Volume
5.27M
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 66.81M | 13.45% |
Operating expense | 79.58M | -8.59% |
Net income | -45.12M | 44.46% |
Net profit margin | -67.53 | 51.04% |
Earnings per share | -0.03 | 98.94% |
EBITDA | -26.36M | 64.75% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 30.59M | -81.71% |
Total assets | 839.67M | -5.74% |
Total liabilities | 579.52M | 3.57% |
Total equity | 260.15M | — |
Shares outstanding | 1.53B | — |
Price to book | 0.92 | — |
Return on assets | -10.41% | — |
Return on capital | -19.32% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -45.12M | 44.46% |
Cash from operations | -14.90M | 88.12% |
Cash from investing | -23.90M | -12,679.68% |
Cash from financing | -3.19M | 86.28% |
Net change in cash | -42.24M | 71.53% |
Free cash flow | -25.47M | 70.87% |
About
CEO
Founded
2008
Website
Employees
65
